The predictive value of multiple artificial intelligence models in axillary lymph node metastasis of breast cancer detected by ultrasound — a network meta-analysis
Frontiers in Oncology · 29.06.2026 · 16
DOI: 10.3389/fonc.2026.1725537 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 29.06.2026. Verfasst von Zhen Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound Medicine, the First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, China. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Foundation for Innovative Research Groups of the National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To compare the diagnostic performance of different AI models in predicting axillary lymph node metastasis in breast cancer detected by ultrasound.
Method
A systematic search strategy was conducted in PubMed, Embase, Web of Science, Cochrane Library, CNKI, and Wanfang Data from July 2015 to July 2025 for diagnostic studies on the prediction of axillary lymph node metastasis in breast cancer. Relevant diagnostic accuracy data were extracted and synthesized. A network meta-analysis was performed to compare the performance of different AI models.
Results
This study finally included 9 studies involving 2,813 patients through strict inclusion and exclusion criteria. The predictive value of 11 artificial intelligence models for axillary lymph node metastasis was assessed. The methodological quality of the included studies was good, and there was no obvious publication bias. The pooled diagnostic odds ratio of all diagnostic methods was 10.92, showing statistically significant heterogeneity (I² = 92%, P < 0.01). Pooled diagnostic performance showed that Boosting-based algorithm models achieved the highest sensitivity (83.0%) and negative predictive value (86.4%), while the Temporal Interlace Network model achieved the highest specificity (90.0%) and positive predictive value (80.0%). Pairwise comparisons revealed that the sensitivity of Boosting-based algorithm models was significantly higher than that of Support Vector Machines (0.17, 95% CI: 0.01–0.33), and the negative predictive value was significantly higher than that of Support Vector Machines (0.09, 95% CI: 0.01–0.17). No statistically significant differences were observed in the predictive performance of the remaining models.
Conclusion
Boosting-based algorithm models showed a possible signal of favorable and balanced predictive value in ultrasound-based axillary lymph node metastasis, though substantial heterogeneity and inconsistency limit definitive conclusions. Systematic review registration https://www.crd.york.ac.uk/prospero/ , identifier CRD420251119253.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound Medicine, the First Affiliated Hospital of Shihezi University, Shihezi, Xinjiang, China.
Förderung
- Foundation for Innovative Research Groups of the National Natural Science Foundation of China
Zitieren
APA
Wang, Z., Dong, J., Cheng, Y., Y, Y., Liu, W., Li, J., & Ma, T. (2026). The predictive value of multiple artificial intelligence models in axillary lymph node metastasis of breast cancer detected by ultrasound — a network meta-analysis. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1725537
Vancouver
Wang Z, Dong J, Cheng Y, Y Y, Liu W, Li J, et al. The predictive value of multiple artificial intelligence models in axillary lymph node metastasis of breast cancer detected by ultrasound — a network meta-analysis. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1725537
BibTeX
@article{Wang2026,
author = {Wang, Zhen and Dong, Jian and Cheng, Yuhang and Y, Yang and Liu, Wen and Li, Jun and Ma, Ting},
title = {The predictive value of multiple artificial intelligence models in axillary lymph node metastasis of breast cancer detected by ultrasound — a network meta-analysis},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1725537}
}
EUVIMED